NDC 55111-455-79 - venlafaxine hydrochloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
55111-455
Requested NDC
55111-455-79
Package NDCs from labels
55111-455-30, 55111-455-60, 55111-455-90, 55111-455-01, 55111-455-05, 55111-455-79, 55111-455-78
Manufacturer
Dr.Reddy's Laboratories Ltd. | Dr.Reddys Laboratories Limited
Effective date
2018-12-06
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
VENLAFAXINE - Dr.Reddy's Laboratories Ltd. | Dr.Reddys Laboratories LimitedDr.Reddy's Laboratories Ltd. | Dr.Reddys Laboratories Limited2018-12-06HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55111-455-01venlafaxine hydrochloride100 in 1 BOTTLECAPSULE, EXTENDED RELEASE1008
55111-455-05venlafaxine hydrochloride500 in 1 BOTTLECAPSULE, EXTENDED RELEASE5008
55111-455-30venlafaxine hydrochloride30 in 1 BOTTLECAPSULE, EXTENDED RELEASE308
55111-455-60venlafaxine hydrochloride60 in 1 BOTTLECAPSULE, EXTENDED RELEASE608
55111-455-78venlafaxine hydrochloride10 in 1 CARTONCAPSULE, EXTENDED RELEASE108
55111-455-79venlafaxine hydrochloride10 in 1 BLISTER PACKCAPSULE, EXTENDED RELEASE108
55111-455-90venlafaxine hydrochloride90 in 1 BOTTLECAPSULE, EXTENDED RELEASE908

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55111-455VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]8Current NDC, Legacy NDC, 7 package rows20181207_7027be98-61d6-a986-c9df-60ceef5f7ff0.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55111-455-05EA - Each55111-45532cbe5b3-3b70-4fc3-a520-af674baf6ddf12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
VENLAFAXINE HYDROCHLORIDEACTIVE INGREDIENT7D7RX5A8MOVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
VENLAFAXINEACTIVE MOIETYGRZ5RCB1QGVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
AMMONIAINACTIVE INGREDIENT5138Q19F1XVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT905HNO1SIHVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
ETHYLCELLULOSESINACTIVE INGREDIENT7Z8S9VYZ4BVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
gelatinINACTIVE INGREDIENT2G86QN327LVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7UVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
POVIDONEINACTIVE INGREDIENTFZ989GH94EVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
SHELLACINACTIVE INGREDIENT46N107B71OVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
talcINACTIVE INGREDIENT7SEV7J4R1UVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6
titanium dioxideINACTIVE INGREDIENT15FIX9V2JPVENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [DR.REDDY'S LABORATORIES LTD.]6

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 125 · 2,496 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 29N1TITANIUM DIOXIDEAmorepacific Corporation5ec7ab15-9cc1-d53a-e063-6294a90a41112026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29W1TITANIUM DIOXIDEAmorepacific Corporation5ec83b87-08bc-7590-e063-6294a90a0b782026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31C1TITANIUM DIOXIDEAmorepacific Corporation5ec857a3-7fd1-6461-e063-6394a90aacd72026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31N1TITANIUM DIOXIDEAmorepacific Corporation5ec871dc-f74e-765c-e063-6394a90a27a52026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 13N1TITANIUM DIOXIDEAmorepacific Corporation5eb19976-6983-3d9e-e063-6394a90a01ee2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17C2TITANIUM DIOXIDEAmorepacific Corporation5eb338c7-e99c-887d-e063-6394a90a977c2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17N1TITANIUM DIOXIDEAmorepacific Corporation5eb363fe-c2b2-9381-e063-6294a90ad0382026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17W1TITANIUM DIOXIDEAmorepacific Corporation5eb39387-7f6b-ce78-e063-6394a90a15ae2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21C2TITANIUM DIOXIDEAmorepacific Corporation5eb3c3ad-8a77-0655-e063-6394a90ae9e02026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21N1TITANIUM DIOXIDEAmorepacific Corporation5eb3ddb5-4e2b-17d4-e063-6394a90aaa552026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 22N1TITANIUM DIOXIDEAmorepacific Corporation5eb415b3-b1ba-42b8-e063-6394a90a90d72026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 21W1TITANIUM DIOXIDEAmorepacific Corporation5eb42062-f298-5186-e063-6294a90ab0432026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 23C2TITANIUM DIOXIDEAmorepacific Corporation5eb44e1b-b24b-6c83-e063-6394a90a4b522026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 23W1TITANIUM DIOXIDEAmorepacific Corporation5eb468db-3c38-922d-e063-6294a90adef82026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 24N1TITANIUM DIOXIDEAmorepacific Corporation5eb4b8ca-eced-b7ff-e063-6394a90aaefe2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 24O1TITANIUM DIOXIDEAmorepacific Corporation5eb4f87a-b4dc-1aa5-e063-6294a90a2ec42026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 25W1TITANIUM DIOXIDEAmorepacific Corporation5eb50784-444e-3bf3-e063-6294a90aa6182026-10-25WarningsExact identifier
unii: 15FIX9V2JP
Clear Eyes Triple ReliefPOLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDEPrestige Brands Holdings, Inc.1269a1a6-843d-4d08-bb3c-c1f3d2e7080d2026-10-23WarningsExact identifier
unii: FZ989GH94E
KARYNG Complete SPF Sunscreen Medium/DarkSUNSCREENKaryng LLC335eee1e-ef1c-41da-e063-6294a90ac2732026-10-20WarningsExact identifier
unii: 15FIX9V2JP
VenlafaxineVENLAFAXINEREMEDYREPACK INC.407134df-8c44-4321-8af5-0a5b60ca65ac2026-10-19Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 7D7RX5A8MO

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.